Onivyde regimen demonstrated statistically significant improvement in overall survival
News
EIT Health’s Venture Centre of Excellence in link-up with ProductLife
ProductLife becomes partner in upholding regulatory and compliance across life sciences
SMC expands guidance for Lokelma to emergency care settings
New access to treatment involves adult patients with hyperkalaemia across Scotland
Rivus presents results from trial evaluating controlled metabolic accelerator
HU6 data demonstrates significant selective weight loss across all body compartments
AstraZeneca’s Farxiga data shows widespread undiagnosed chronic kidney disease
INSIDE-CKD study involves patients from across France, Germany, Italy, the US and Japan
Leva Clinic fundraises £3m for UK’s first digital chronic pain platform
Funding will be used to broaden partnerships with the NHS and improve patient experience
Digital cognitive behaviour therapies recommended by NICE across the NHS
Treatment will assist young people and children with symptoms of mild-to-moderate anxiety
Lhasa and Optibrium improve predictive modelling for drug-metabolising enzymes
Research shows how novel predictive models develop drug design and reduce toxicity
Xerion and MDC secure vital brain tumour treatment funding
Grant from Innovate UK SMART awarded to accelerate clinical trial progress
Aelix and Gilead announce results of HIV infection candidate
The study evaluated the safety, efficacy and immunogenicity of AELIX’s HIV vaccine
Everything Genetic links up with Caris for UK distribution of MI Tumor Seek
MI Tumor Seek is a molecular profiling service used to guide the management of advanced cancer
New device launched for diagnosing prostate cancer
CamPROBE may save vital time and money while reducing the risk of infection
GigaGen’s use of 2G UNicTM tech extended by ProteoNic
ProteoNic’s protein expression technology improves recombinant protein production
GSK’s anaemia drug gets FDA advisory committee support for patients on dialysis
A final decision for daprodustat by the FDA is expected by 1 February 2023
New evidence review uncovers ‘significant’ link between particulate matter and dementia
Information from 17 existing studies was reviewed, involving 91 million people
